Evaluating group therapy for veterans with military sexual trauma
Efficacy of Virtual Warrior Renew Therapy for Veterans Who Experienced Military Sexual Trauma
This study tests two types of group therapy for veterans who have experienced military sexual trauma to see which one helps reduce their mental health symptoms better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 134 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Seattle Institute for Biomedical and Clinical Research Academic / other |
| Locations | 3 sites (Portland, Oregon and 2 other locations) |
| Trial ID | NCT05776719 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of two group therapy approaches, Warrior Renew and Health & Wellness, for veterans who have experienced military sexual trauma (MST). The research aims to determine if either treatment is more effective in reducing mental health symptoms associated with MST and PTSD. Participants will engage in virtual group therapy sessions over a period of 16 weeks, allowing for a comprehensive assessment of treatment outcomes. The study also seeks to identify any gender differences in treatment efficacy that may inform future therapeutic approaches.
Who should consider this trial
Good fit: Ideal candidates are veterans aged 18 to 75 who have experienced military sexual trauma and are currently receiving care from a VA medical or mental health provider.
Not a fit: Patients with current suicidal ideation, severe mental health disorders, or impaired decision-making capacity may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide effective group therapy options for veterans suffering from the effects of military sexual trauma.
How similar studies have performed: Previous studies have shown promise in group therapy approaches for PTSD, suggesting potential success for this novel application in MST treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Has established care with VA medical or mental health provider. 2. Reports having experienced military sexual trauma. 3. Between the ages of 18 and 75. 4. Is an outpatient and is able to comply with all study procedures, including the eight weeks of group treatment and the assessment measures. 5. Positive screen on the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5). 6. Able to participate in virtual group therapy via telehealth. Exclusion Criteria: 1. Impaired decision-making capacity that in the clinical judgment of their provider would affect their ability to provide informed consent. 2. Current/active suicidal ideation as evidenced by a positive screen on the Columbia Suicide Severity Rating Scale (C-SSRS), or a suicide attempt or psychiatric hospitalization within the past year 3. Current or past diagnosis of schizophrenia, schizoaffective disorder, delusional disorder, psychotic or dissociative disorders. 4. Current/active diagnosis of a substance use disorder or an alcohol use disorder as measured by the Alcohol Use Disorders Identification Test-Concise (AUDIT-C).66 5. Unable to read English. 6. Currently receiving trauma-focused group or individual psychotherapy treatment. (Previous psychotherapy or current pharmacotherapy is acceptable). 7. Concurrently enrolled in another research protocol involving a mental health intervention during this study 8. Has had previous Warrior Renew treatment.
Where this trial is running
Portland, Oregon and 2 other locations
- VA Portland Health Care System — Portland, Oregon, United States (Recruiting)
- VA Puget Sound Health Care System — Seattle, Washington, United States (Recruiting)
- VA Puget Sound Health Care System American Lake Division — Tacoma, Washington, United States (Recruiting)
Study contacts
- Principal investigator: Amanda E Wood, PhD — VA Puget Sound Health Care System
- Study coordinator: Amanda E Wood, PhD
- Email: amanda.wood@va.gov
- Phone: 253-583-1651
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.